systemic biologics

Views & Analysis

Psoriasis is a tricky disease to manage, as drawbacks and side effects loom with each and every type of treatment.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.